Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 11:55 am Purchase |
2024-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
JANUS HENDERSON GROUP PLC JHG |
14,080,219 14.600% |
753,332 (+5.65%) |
Filing History |
| 2024-11-14 11:50 am Purchase |
2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL |
JANUS HENDERSON GROUP PLC JHG |
13,326,887 13.800% |
13,326,887 (New Position) |
Filing History |
| 2024-11-14 06:10 am Sale |
2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL |
RTW Investments, LP | 0 0.000% |
-9,196,186 (Position Closed) |
Filing History |
| 2024-11-13 5:58 pm Sale |
2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL |
Polar Capital Holdings Plc | 4,803,899 4.990% |
-1,947,883 (-28.85%) |
Filing History |
| 2024-11-13 5:00 pm Sale |
2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL |
COWEN AND COMPANY, LLC | 0 0.000% |
-3,732,778 (Position Closed) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL |
BLACKROCK INC BLK |
5,257,004 5.500% |
0 (Unchanged) |
Filing |
| 2024-10-24 2:02 pm Purchase |
2024-09-30 | 13G | Avadel Pharmaceuticals plc AVDL |
BLACKROCK INC BLK |
5,257,004 5.500% |
5,257,004 (New Position) |
Filing |
| 2024-02-14 07:11 am Purchase |
2023-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
RTW Investments, LP | 9,196,186 9.990% |
3,454,247 (+60.16%) |
Filing History |
| 2024-02-13 5:54 pm Purchase |
2023-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
JANUS HENDERSON GROUP PLC JHG |
11,125,330 12.400% |
1,681,688 (+17.81%) |
Filing History |
| 2024-02-13 4:39 pm Purchase |
2023-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
Tontine Asset Associates, LLC | 5,685,350 6.330% |
494,745 (+9.53%) |
Filing History |
| 2024-02-13 09:40 am Purchase |
2023-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
Polar Capital Holdings Plc | 6,751,782 7.510% |
3,957,109 (+141.59%) |
Filing History |
| 2024-02-12 08:20 am Purchase |
2024-02-12 | 13G | Avadel Pharmaceuticals plc AVDL |
KOTLER KEVIN | 3,716,242 4.100% |
594,142 (+19.03%) |
Filing History |
| 2023-08-10 3:25 pm Purchase |
2023-07-31 | 13G | Avadel Pharmaceuticals plc AVDL |
JANUS HENDERSON GROUP PLC JHG |
9,443,642 12.300% |
9,443,642 (New Position) |
Filing History |
| 2023-03-09 4:13 pm Purchase |
2023-02-14 | 13G | Avadel Pharmaceuticals plc AVDL |
KOTLER KEVIN | 3,122,100 5.100% |
265,110 (+9.28%) |
Filing History |
| 2023-02-14 4:05 pm Purchase |
2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
Tontine Asset Associates, LLC | 5,190,605 8.400% |
1,015,623 (+24.33%) |
Filing History |
| 2023-02-14 10:01 am Sale |
2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
RTW Investments, LP | 5,741,939 9.300% |
-68,201 (-1.17%) |
Filing History |
| 2023-02-13 5:42 pm Sale |
2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
Vivo Opportunity LLC | 2,251,663 3.600% |
-149,613 (-6.23%) |
Filing History |
| 2023-02-13 4:58 pm Sale |
2022-12-31 | 13G | Avadel Pharmaceuticals plc AVDL |
KOTLER KEVIN | 2,856,990 4.600% |
-583,222 (-16.95%) |
Filing History |
| 2022-06-06 4:57 pm Purchase |
2022-05-26 | 13G | Avadel Pharmaceuticals plc AVDL |
KOTLER KEVIN | 3,440,212 5.800% |
3,440,212 (New Position) |
Filing History |
| 2022-06-03 4:10 pm Purchase |
2022-05-27 | 13G | Avadel Pharmaceuticals plc AVDL |
Tontine Asset Associates, LLC | 4,174,982 7.070% |
4,174,982 (New Position) |
Filing History |